Lenvervimab

Names

[ CAS No. ]:
2055006-79-4

[ Name ]:
Lenvervimab

Biological Activity

[Description]:

Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2].

[Related Catalog]:

Research Areas >> Infection

Signaling Pathways >> Anti-infection >> HBV

[In Vitro]

Lenvervimab (1 nM-1 μM，16 小时) 抑制感染 HBV 的 HepG2-NTCP 细胞中的 HBV 感染[1]。 Lenvervimab 可识别 HBV 感染的许多病毒基因型和临床变异体[1]。 Western Blot Analysis[1] Cell Line: HepG2-NTCP cells infected with HBV Concentration: 1 nM-1 μM Incubation Time: 16 h Result: Inhibited viral expression of the surface antigen HBsAg (hepatitis B virus surface antigen) and the core protein HBcAg.

[References]

[1]. Jeong GU, et al. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One. 2020 Aug 13;15(8):e0236704.

[2]. Lee HW, et al. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020 Dec;18(13):3043-3045.e1.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.